Stocktoria
CYTOKINETICS INC CYTK
CYTOKINETICS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0M | $18.5M | $7.5M | $94.6M | $70.4M | $55.8M | $26.9M | $31.5M | $13.4M | $106.4M |
| R&D expense | $416.0M | $339.4M | $330.1M | $240.8M | $159.9M | $97.0M | $86.1M | $89.1M | $90.3M | $59.9M |
| Operating income | -$612.3M | -$536.2M | -$496.2M | -$324.2M | -$186.3M | -$93.9M | -$98.9M | -$88.9M | -$113.4M | $18.7M |
| Interest expense | $45.6M | $37.7M | $28.3M | $19.4M | $16.4M | $16.0M | $6.6M | $3.8M | $3.0M | $2.7M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$785.0M | -$589.5M | -$526.2M | -$389.0M | -$215.3M | -$127.3M | -$121.7M | -$106.3M | -$127.8M | $16.5M |
| EPS (diluted) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | — | — | $-2.59 | $0.39 |
| Operating cash flow | -$510.0M | -$395.9M | -$414.3M | -$299.5M | -$142.5M | $8.9M | -$90.9M | -$101.2M | -$101.8M | $37.0M |
| Free cash flow | -$534.8M | -$399.8M | -$415.7M | -$310.9M | -$191.4M | -$2.1M | -$93.5M | -$102.1M | -$104.6M | $35.4M |
| Cash & equivalents | $122.5M | $94.9M | $113.0M | $65.6M | $112.7M | $83.0M | $36.4M | $42.3M | $125.2M | $66.9M |
| Inventory | $0 | — | — | — | — | — | — | — | — | — |
| Total assets | $1.4B | $1.4B | $824.3M | $1.0B | $841.3M | $533.8M | $289.8M | $211.2M | $294.8M | $170.1M |
| Total liabilities | $2.1B | $1.5B | $1.2B | $1.1B | $597.5M | $420.4M | $300.8M | $185.2M | $185.0M | $75.8M |
| Shareholders' equity | -$659.6M | -$135.4M | -$386.3M | -$107.9M | $243.9M | $113.4M | -$10.9M | $25.9M | $109.8M | $94.4M |
Growth · year-over-year · Revenue CAGR -2.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +376.6% | +145.3% | -92.0% | +34.3% | +26.2% | +107.8% | -14.7% | +135.6% | -87.4% | +271.3% |
| Net income growth | — | — | — | — | — | — | — | — | -876.7% | — |
| EPS growth | — | — | — | — | — | — | — | — | -764.1% | — |
| Free cash flow growth | — | — | — | — | — | — | — | — | -395.7% | +718.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.